Edesa Biotech, Inc. (EDSA)

Data as of Oct 6, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch EDSA

See up to 3 months of EDSA. The 7-day demo opens the 1M and 3M ranges and puts EDSA on your watchlist.

Latest EDSA insider trades

Michael J. Brooks - Officer
Open-market purchase$3K
Feb 26, 2026
Pardeep Nijhawan - Officer
Open-market purchase$7K
Mar 10, 2026

About Edesa Biotech, Inc. (EDSA)

Edesa Biotech, Inc. is an SEC registrant, filing under CIK 0001540159, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for EDSA on EDGAR

EDSA Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Grant or award	3	17,931

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

EDSA insider transactions (Form 4)

36 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Oct 5, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	6,893^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Sep 1, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	5,714^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Aug 3, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	5,324^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Jul 2, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	3,378^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Jun 16, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	153,550^{footnote F1}	$5.21^{footnote F1}	$800K
Footnote F1 (price, shares): On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50.
Jun 1, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	1,671^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
May 27, 2026	Patrick Marshall - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 27, 2026	Sean Arthur Macdonald - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 27, 2026	Joan Chypyha - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 27, 2026	Peter J. Weiler - Officer	Grant or award	Common Shares	64,609^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.
May 27, 2026	Michael J. Brooks - Officer	Grant or award	Common Shares	64,609^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.
May 27, 2026	Carlo Sistilli - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 27, 2026	Charles V. Olson - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 27, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	96,913^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.
May 27, 2026	da David Liu - Director	Grant or award	Common Shares	19,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
May 1, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	1,159^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Apr 1, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	2,578^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Feb 26, 2026	Michael J. Brooks - Officer	Open-market purchase	Common Shares	2,000	$1.57	$3K
Mar 10, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	1,000	$6.60	$7K
Mar 5, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	10,000	$3.90	$39K
Mar 4, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	10,000	$4.26	$43K
Mar 3, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	10,000	$3.63	$36K
Mar 2, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	2,000	$2.00	$4K
Mar 2, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	1,000	$2.28	$2K
Feb 26, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	20,571	$1.58^{footnote F1}	$32K
Mar 2, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	10,016	$0.00^{footnote F2}	-
Feb 27, 2026	Pardeep Nijhawan - Officer	Open-market purchase	Common Shares	30,000	$2.22^{footnote F3}	$67K
Footnote F1 (price): The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.58 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of… Full note on SEC EDGAR Footnote F2 (price): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. Footnote F3 (price): The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.2295 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff… Full note on SEC EDGAR
Feb 2, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	11,168^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Jan 5, 2026	Pardeep Nijhawan - Officer	Grant or award	Common Shares	10,444	$0.00	-
Dec 1, 2025	Pardeep Nijhawan - Officer	Grant or award	Common Shares	8,766^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Nov 3, 2025	Pardeep Nijhawan - Officer	Grant or award	Common Shares	6,968^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Oct 2, 2025	Pardeep Nijhawan - Officer	Grant or award	Common Shares	5,908	$0.00^{footnote F1}	-
Footnote F1 (price): Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Sep 11, 2025	Pardeep Nijhawan - Officer	Grant or award	Common Shares	5,981	$0.00	-

Recent EDSA Form 8-K filings

Read EDSA company news

Aug 20, 2026Item 1.01, 8.01, 9.01

Read the filing on SEC EDGAR

Aug 13, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 11, 2026Item 1.01, 3.02, 7.01, 9.01

Read the filing on SEC EDGAR

Jun 5, 2026Item 8.01

EDSA insider trading FAQ

What is the latest insider trade for EDSA?

Edesa Biotech, Inc. (EDSA) had 3 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for EDSA runs to 36 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying EDSA stock?

No insider purchases of EDSA were filed in the last 90 days. 9 purchases are on record for this company.

How many insiders are selling EDSA stock?

No insider sales of EDSA were filed in the last 90 days.

Where can I see EDSA SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects EDSA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 6, 2026 - Pardeep Nijhawan view on EDGAR
Sep 1, 2026 - Pardeep Nijhawan view on EDGAR
Aug 4, 2026 - Pardeep Nijhawan view on EDGAR
Jul 2, 2026 - Pardeep Nijhawan view on EDGAR
Jun 16, 2026 - Pardeep Nijhawan view on EDGAR
Jun 1, 2026 - Pardeep Nijhawan view on EDGAR
May 29, 2026 - Patrick Marshall view on EDGAR
May 29, 2026 - Sean Arthur Macdonald view on EDGAR
May 29, 2026 - Joan Chypyha view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where EDSA's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow EDSA with a 7-day demo

EDSA on your watchlist
Every EDSA Form 4 filing on record
Up to 3 months of EDSA price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Grant or award

17,931

Date

Insider

Transaction

Security

Price

Value

Oct 5, 2026